Breast Milk Retinol Concentration Improvement with B-carotene or Vitamin A in Lactating Filipino Women
b-carotene
+ retinyl palmitate
+ placebo
Treatment Study
Summary
Study start date: January 1, 2013
Actual date on which the first participant was enrolled.This study focuses on lactating Filipino women and explores the impact of small daily doses of B-carotene or Vitamin A on the concentration of retinol, a form of Vitamin A, in breast milk. The main goal is to understand if this supplementation can increase the retinol levels in breast milk. This research is important as it could potentially improve the vitamin A status of lactating women, which is crucial for both the mother's and infant's health. During this study, participants receive either B-carotene or retinyl palmitate, a type of Vitamin A, as a supplement six days a week for three weeks. The dosage is approximately 600 ug RAE per day. The study measures the concentration of retinol in breast milk at the beginning and after the three-week supplementation period. This helps to evaluate if the supplementation is effective in increasing the retinol levels. The study also assesses different methods for collecting breast milk samples in a community setting.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.85 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Female
Biological sex of participants that are eligible to enroll.From 18 to 35 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.3 intervention groups are designated in this study
33.333% chance of being blinded to the placebo group
Treatment Groups
Group I
ExperimentalGroup II
Active ComparatorGroup III
PlaceboStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
University of California, Davis
Davis, United StatesOpen University of California, Davis in Google Maps